Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | SGMT | QNCX | ||
| Company | Editas Medicine | Sagimet Biosciences Inc Series A | Quince Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.99 | 6.00 | 3.50 | ||
| High | 2.06 | 6.34 | 3.72 | ||
| Low | 1.92 | 5.95 | 3.30 | ||
| Latest | 2.02 | 6.28 | 3.42 | ||
| Change | -0.01 | +0.14 | -0.13 | ||
| % Change | -0.49% | +2.28% | -3.66% | ||
| Volume | 1,738,900 | 501,000 | 1,549,200 | ||
| 20-Day Average Volume | 1,877,795 | 546,465 | 901,620 | ||
| Previous Close | 2.03 | 6.14 | 3.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.13 | 6.00 | 3.19 | ||
| 20-Day Raw Stochastic | 18.33% | 70.83% | 69.35% | ||
| 20-Day Relative Strength | 39.59 | 49.14 | 55.80 | ||
| Weighted Alpha | -5.78 | -1.67 | +23.27 | ||
| Today's Opinion | 88% Sell | 48% Sell | 88% Buy | ||
| Previous Opinion | 88% Sell | 48% Sell | 88% Buy | ||
| Last Month's Opinion | 8% Sell | 40% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.16% since 01/12/26 | +0.64% since 01/12/26 | +15.93% since 01/12/26 | ||
| Low | 1.92 on 01/20/26 | 5.95 on 01/20/26 | 2.82 on 01/13/26 | ||
| High | 2.28 on 01/14/26 | 6.42 on 01/15/26 | 3.72 on 01/20/26 | ||
| 1-Month | |||||
| %Chg | -13.68% since 12/19/25 | unch since 12/19/25 | -4.20% since 12/19/25 | ||
| Low | 1.92 on 01/20/26 | 5.43 on 01/06/26 | 2.56 on 01/12/26 | ||
| High | 2.44 on 12/22/25 | 6.63 on 01/09/26 | 3.80 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | -51.21% since 10/20/25 | -19.80% since 10/20/25 | +84.86% since 10/20/25 | ||
| Low | 1.92 on 01/20/26 | 5.43 on 01/06/26 | 1.44 on 11/11/25 | ||
| High | 4.21 on 10/21/25 | 9.46 on 10/27/25 | 4.55 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | -26.81% since 07/18/25 | -33.26% since 07/18/25 | +80.95% since 07/18/25 | ||
| Low | 1.92 on 01/20/26 | 5.43 on 01/06/26 | 1.44 on 11/11/25 | ||
| High | 4.54 on 10/08/25 | 11.41 on 07/25/25 | 4.55 on 12/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 198,167 | 199,685 | 197,668 | ||
| Shares Outstanding, K | 97,619 | 32,522 | 55,681 | ||
| Annual Sales | 32,310,000 | 0 | 0 | ||
| Annual Net Income | -237,090,000 | -45,570,000 | -56,830,000 | ||
| Last Quarter Sales | 7,540,000 | 0 | 0 | ||
| Last Quarter Net Income | -25,120,000 | -12,910,000 | -13,440,000 | ||
| 60-Month Beta | 2.16 | 3.39 | 1.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 11/10/25 | -0.40 on 11/13/25 | -0.25 on 11/12/25 | ||
| Latest Earnings Date | 03/04/26 | 03/11/26 | 03/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||